Related Experiment Video

Updated: Oct 9, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Continuation of warfarin-nafcillin interaction during dicloxacillin therapy

A T Taylor1, D C Pritchard, A O Goldstein

  • 1Department of Pharmacy Practice, University of Georgia College of Pharmacy, Athens.

The Journal of Family Practice
|August 1, 1994
PubMed

Insights

Warfarin drug interactions with nafcillin and dicloxacillin require significantly higher warfarin doses. This case report highlights potential risks and management adjustments for anticoagulation therapy during penicillin co-administration.

Area of Science:

  • Pharmacology and Drug Interactions
  • Clinical Pharmacy

Background:

  • Warfarin is a widely used anticoagulant, necessitating careful management of drug interactions.
  • Interactions between warfarin and penicillinase-resistant penicillins are infrequently documented.
  • Understanding these interactions is crucial for maintaining therapeutic anticoagulation.

Observation:

  • A single patient case involving concurrent warfarin and nafcillin therapy is presented.
  • The patient subsequently received warfarin and dicloxacillin, allowing for comparative analysis.
  • Clinical effects were monitored via prothrombin time (PT) and warfarin dosage requirements.

Findings:

  • Nafcillin therapy necessitated up to a 4.5-fold increase in warfarin dosage for adequate anticoagulation.
  • Dicloxacillin therapy also required increased warfarin dosing, though it was gradually reduced.
  • The stabilized warfarin maintenance dose remained higher than the pre-nafcillin baseline.

Implications:

  • Nafcillin and dicloxacillin may significantly reduce warfarin's anticoagulant efficacy.
  • Close monitoring of PT and warfarin dosage adjustments are essential during co-administration.
  • These findings suggest a clinically relevant interaction between these penicillins and warfarin.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor08:22

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor

Published on: October 9, 2017

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...